Kevin Lee, Bicycle Therapeutics CEO
April 9, 2022 11:36 AM EDTUpdated April 14, 12:46 PM
R&D

Ear­ly win­ner emerges at #AACR22 as a transat­lantic hy­brid posts an up­beat snap­shot for urothe­lial can­cer

John Carroll

Editor & Founder

NEW OR­LEANS — Af­ter get­ting off to a rough start with a weak per­for­mance from Ru­bius Ther­a­peu­tics on Fri­day, the mood at AACR this …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

You bet your life: Af­ter I was di­ag­nosed with a rare can­cer, I dis­cov­ered how a small band of physi­cian-sci­en­tists ...

Biotech VC firm out­lines plans for $100M fund

Why did Eli Lil­ly ask a pa­tient on a com­pound­ed GLP-1 drug for their med­ical in­for­ma­tion?

Reg­u­la­to­ry RNA start­up CAMP4 files for IPO as more biotechs line up list­ings

No­vo says its CB1 drug helped shed weight, but ef­fi­ca­cy and safe­ty ques­tions re­main

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times